Published in Eur Arch Otorhinolaryngol on January 04, 2014
Expression of serine/glycine metabolism-related proteins is different according to the thyroid cancer subtype. J Transl Med (2016) 0.79
Immunohistochemistry is highly sensitive and specific for detecting the BRAF V600E mutation in papillary thyroid carcinoma. Int J Clin Exp Pathol (2015) 0.78
Comparison of the clinicopathological behavior of the follicular variant of papillary thyroid carcinoma and classical papillary thyroid carcinoma: A systematic review and meta-analysis. Mol Clin Oncol (2015) 0.75
Expression of glutamine metabolism-related proteins in thyroid cancer. Oncotarget (2016) 0.75
Noninferior response in BRAF(V600E) mutant nonmetastatic papillary thyroid carcinoma to radioiodine therapy. Eur J Nucl Med Mol Imaging (2016) 0.75
BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study. J Clin Endocrinol Metab (2008) 3.38
BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer. J Clin Oncol (2009) 3.02
The oncogene BRAF V600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+/I- targeting to the membrane. Endocr Relat Cancer (2006) 2.52
The association of the BRAF(V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis. Cancer (2011) 2.36
BRAF mutation in papillary thyroid carcinoma in a Japanese population: its lack of correlation with high-risk clinicopathological features and disease-free survival of patients. Endocr J (2008) 2.06
Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma. J Clin Endocrinol Metab (2007) 1.95
BRAF(V600E) mutation and the biology of papillary thyroid cancer. Endocr Relat Cancer (2008) 1.83
The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma. Clin Endocrinol (Oxf) (2006) 1.77
BRAF mutations in an Italian cohort of thyroid cancers. Clin Endocrinol (Oxf) (2004) 1.75
The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study. J Clin Endocrinol Metab (2012) 1.62
Association of high iodine intake with the T1799A BRAF mutation in papillary thyroid cancer. J Clin Endocrinol Metab (2009) 1.55
Correlation between the BRAF V600E mutation and tumor invasiveness in papillary thyroid carcinomas smaller than 20 millimeters: analysis of 1060 cases. J Clin Endocrinol Metab (2010) 1.50
Influence of the BRAF V600E mutation on expression of vascular endothelial growth factor in papillary thyroid cancer. J Clin Endocrinol Metab (2006) 1.43
BRAF(V600E) mutation is associated with an increased risk of nodal recurrence requiring reoperative surgery in patients with papillary thyroid cancer. Surgery (2010) 1.36
The BRAF mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma. Clin Endocrinol (Oxf) (2005) 1.35
Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature. Endocr Relat Cancer (2006) 1.33
A high percentage of BRAFV600E alleles in papillary thyroid carcinoma predicts a poorer outcome. J Clin Endocrinol Metab (2012) 1.30
Clinical significance of BRAF (V600E) mutation and Ki-67 labeling index in papillary thyroid carcinomas. Anticancer Res (2007) 1.29
Immunohistochemical detection of the BRAF V600E-mutated protein in papillary thyroid carcinoma. Am J Surg Pathol (2012) 1.26
BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma. Clin Endocrinol (Oxf) (2007) 1.24
BRAF V600E mutation is associated with tumor aggressiveness in papillary thyroid cancer. World J Surg (2012) 1.23
BRAFV600E mutation in the pathogenesis of a large series of papillary thyroid carcinoma in Czech Republic. J Endocrinol Invest (2009) 1.19
Role of BRAF in thyroid oncogenesis. Clin Cancer Res (2011) 1.17
Correlation between BRAF mutation and the clinicopathological parameters in papillary thyroid carcinoma with particular reference to follicular variant. Hum Pathol (2010) 1.15
No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan. Clin Endocrinol (Oxf) (2005) 1.13
BRAF and K-RAS mutation in a Greek papillary and medullary thyroid carcinoma cohort. Anticancer Res (2008) 1.12
Clinical implication of highly sensitive detection of the BRAF V600E mutation in fine-needle aspirations of thyroid nodules: a comparative analysis of three molecular assays in 4585 consecutive cases in a BRAF V600E mutation-prevalent area. J Clin Endocrinol Metab (2012) 1.12
Analysis of differential BRAF(V600E) mutational status in multifocal papillary thyroid carcinoma: evidence of independent clonal origin in distinct tumor foci. Cancer (2006) 1.10
Prediction of occult central lymph node metastasis in papillary thyroid carcinoma by preoperative BRAF analysis using fine-needle aspiration biopsy: a prospective study. J Clin Endocrinol Metab (2012) 1.09
Poorer prognosis and higher prevalence of BRAF (V600E) mutation in synchronous bilateral papillary thyroid carcinoma. Ann Surg Oncol (2011) 1.09
Both BRAF V600E mutation and older age (≥ 65 years) are associated with recurrent papillary thyroid cancer. Ann Surg Oncol (2011) 1.04
BRAFV600E mutation does not serve as a prognostic factor in Korean patients with papillary thyroid carcinoma. Auris Nasus Larynx (2011) 1.03
Surgical results of thyroid nodules according to a management guideline based on the BRAF(V600E) mutation status. J Clin Endocrinol Metab (2011) 1.03
Is the BRAF(V600E) mutation useful as a predictor of preoperative risk in papillary thyroid cancer? Am J Surg (2011) 1.00
BRAF(V600E) mutation analysis in papillary thyroid carcinoma: is it useful for all patients? World J Surg (2014) 1.00
Central neck dissection for papillary thyroid cancer. Cancer Control (2011) 0.98
Detection of BRAF mutation in thyroid papillary carcinomas by mutant allele-specific PCR amplification (MASA). Eur J Endocrinol (2006) 0.98
Approach to and treatment of differentiated thyroid carcinoma. Med Clin North Am (2012) 0.97
Lack of correlation between BRAF V600E mutational status and the expression profile of a distinct set of miRNAs in papillary thyroid carcinoma. Horm Metab Res (2009) 0.96
Mutant BRAF(T1799A) can be detected in the blood of papillary thyroid carcinoma patients and correlates with disease status. J Clin Endocrinol Metab (2009) 0.95
BRAF V600E mutation in papillary thyroid carcinoma: significant association with node metastases and extra thyroidal invasion. Endocr Pathol (2012) 0.94
Is BRAF mutation associated with lymph node metastasis in patients with papillary thyroid cancer? Surgery (2012) 0.94
BRAFV600E mutation in papillary thyroid microcarcinoma: a genotype-phenotype correlation. Mod Pathol (2012) 0.93
Papillary thyroid carcinoma with BRAFV600E mutation: sonographic prediction. AJR Am J Roentgenol (2010) 0.93
Clinical utility of immunohistochemistry for the detection of the BRAF v600e mutation in papillary thyroid carcinoma. Surgery (2013) 0.90
BRAFV600E mutation, TIMP-1 upregulation, and NF-κB activation: closing the loop on the papillary thyroid cancer trilogy. Endocr Relat Cancer (2011) 0.90
Hypermethylation of the DNA mismatch repair gene hMLH1 and its association with lymph node metastasis and T1799A BRAF mutation in patients with papillary thyroid cancer. Cancer (2008) 0.90
BRAF V600E mutation does not predict recurrence after long-term follow-up in TNM stage I or II papillary thyroid carcinoma patients. APMIS (2011) 0.90
Detection of BRAF(V600E) Mutations in Papillary Thyroid Carcinomas by Peptide Nucleic Acid Clamp Real-Time PCR: A Comparison with Direct Sequencing. Korean J Pathol (2012) 0.89
BRAF(V600E) mutation in Turkish patients with papillary thyroid cancer: strong correlation with indicators of tumor aggressiveness. Endocrine (2012) 0.89
BRAF (V600E) mutation analysis in papillary thyroid carcinomas by peptide nucleic acid clamp real-time PCR. Ann Surg Oncol (2012) 0.89
Activation of nuclear factor-κB contributes to growth and aggressiveness of papillary thyroid carcinoma. Pathol Res Pract (2013) 0.88
Unique patterns of tumor growth related with the risk of lymph node metastasis in papillary thyroid carcinoma. Mod Pathol (2010) 0.87
BRAF(V600E) mutation influences hypoxia-inducible factor-1alpha expression levels in papillary thyroid cancer. Mod Pathol (2010) 0.87
Thyroid stimulating hormone increases iodine uptake by thyroid cancer cells during BRAF silencing. J Surg Res (2012) 0.86
Clinical significance of BRAF mutation in thyroid papillary cancer. Otolaryngol Head Neck Surg (2013) 0.86
Dual specificity phosphatase 6 as a predictor of invasiveness in papillary thyroid cancer. Eur J Endocrinol (2012) 0.86
In papillary thyroid carcinoma BRAFV600E is associated with increased expression of the urokinase plasminogen activator and its cognate receptor, but not with disease-free interval. Clin Endocrinol (Oxf) (2012) 0.85
Mutational and clinico-pathological analysis of papillary thyroid carcinoma in Serbia. Endocr J (2011) 0.84
Lack of association between BRAF V600E mutation and mitogen-activated protein kinase activation in papillary thyroid carcinoma. Pathol Int (2007) 0.84
The role of BRAFV600E mutation and ultrasonography for the surgical management of a thyroid nodule suspicious for papillary thyroid carcinoma on cytology. Ann Surg Oncol (2009) 0.83
Papillary thyroid carcinomas with and without BRAF V600E mutations are morphologically distinct. Histopathology (2012) 0.83
Notch1 receptor as a marker of lymph node metastases in papillary thyroid cancer. Cancer Sci (2012) 0.83
Detection of BRAF V600E mutation with thyroid tissue using pyrosequencing: comparison with PNA-clamping and real-time PCR. Am J Clin Pathol (2013) 0.82
BRAFV600E mutation and X-linked inhibitor of apoptosis expression in papillary thyroid carcinoma. Thyroid (2009) 0.81
Shifted termination assay (STA) fragment analysis to detect BRAF V600 mutations in papillary thyroid carcinomas. Diagn Pathol (2013) 0.81
BRAFV600E mutation in fine-needle aspiration aspirates: Association with poorer prognostic factors in larger papillary thyroid carcinomas. Head Neck (2012) 0.81
BRAF mutation analysis and sonography as adjuncts to fine-needle aspiration cytology of papillary thyroid carcinoma: their relationships and roles. AJR Am J Roentgenol (2012) 0.81
Different structural components of conventional papillary thyroid carcinoma display mostly identical BRAF status. Int J Cancer (2007) 0.80
BRAF(V600E) mutation analysis from May-Grünwald Giemsa-stained cytological samples as an adjunct in identification of high-risk papillary thyroid carcinoma. Endocr Pathol (2011) 0.79
BRAFV600E status and clinical characteristics in solitary and multiple papillary thyroid carcinoma: experience of 512 cases at a clinical center in China. World J Surg Oncol (2012) 0.79
Intratumoural lymph vessel density is related to presence of lymph node metastases and separates encapsulated from infiltrative papillary thyroid carcinoma. Virchows Arch (2011) 0.78
Role of BRAFV600E mutation analysis and second cytologic review of fine-needle aspiration for evaluating thyroid nodule. Cancer Cytopathol (2011) 0.78
Progression of solitary and multifocal papillary thyroid carcinoma - a retrospective study of 368 patients. Chin Med J (Engl) (2012) 0.77
Association between STAT1 activity and BRAF mutations in papillary thyroid carcinomas. J Surg Oncol (2012) 0.75
Aortic calcification and the risk of osteoporosis and fractures. J Clin Endocrinol Metab (2004) 3.59
The associations between maternal factors during pregnancy and the risk of childhood acute lymphoblastic leukemia: A meta-analysis. Pediatr Blood Cancer (2015) 2.77
Efficient genome editing in plants using a CRISPR/Cas system. Cell Res (2013) 2.57
Glacial-interglacial Indian summer monsoon dynamics. Science (2011) 2.31
Multigeneration analysis reveals the inheritance, specificity, and patterns of CRISPR/Cas-induced gene modifications in Arabidopsis. Proc Natl Acad Sci U S A (2014) 2.26
Interplay between the Westerlies and Asian monsoon recorded in Lake Qinghai sediments since 32 ka. Sci Rep (2012) 1.95
Leukocyte DNA damage and wound infection after nitrous oxide administration: a randomized controlled trial. Anesthesiology (2013) 1.59
Relationship between domestic and wild birds in live poultry market and a novel human H7N9 virus in China. J Infect Dis (2013) 1.50
Forecasting incidence of hemorrhagic fever with renal syndrome in China using ARIMA model. BMC Infect Dis (2011) 1.48
South China Sea hydrological changes and Pacific Walker Circulation variations over the last millennium. Nat Commun (2011) 1.29
The conduct of drug metabolism studies considered good practice (II): in vitro experiments. Curr Drug Metab (2007) 1.21
miR-206 inhibits gastric cancer proliferation in part by repressing cyclinD2. Cancer Lett (2013) 1.21
Signaling of cell fate determination by the TPD1 small protein and EMS1 receptor kinase. Proc Natl Acad Sci U S A (2008) 1.19
Tumor suppressor functions of miR-133a in colorectal cancer. Mol Cancer Res (2013) 1.15
Linear non-competitive inhibition of solubilized human gamma-secretase by pepstatin A methylester, L685458, sulfonamides, and benzodiazepines. J Biol Chem (2002) 1.14
Comparative pharmacokinetics of baicalin after oral administration of pure baicalin, Radix scutellariae extract and Huang-Lian-Jie-Du-Tang to rats. J Ethnopharmacol (2006) 1.13
Bone acquisition in healthy children and adolescents: comparisons of dual-energy x-ray absorptiometry and computed tomography measures. J Clin Endocrinol Metab (2005) 1.12
Preliminary evidence for a 1000-year-old tsunami in the South China Sea. Sci Rep (2013) 1.12
Differential roles of miR-199a-5p in radiation-induced autophagy in breast cancer cells. FEBS Lett (2013) 1.10
Chronic inhibition of cardiac Kir2.1 and HERG potassium channels by celastrol with dual effects on both ion conductivity and protein trafficking. J Biol Chem (2006) 1.10
Measuring access to medicines: a survey of prices, availability and affordability in Shaanxi province of China. PLoS One (2013) 1.05
The mechanism of gamma-secretase: multiple inhibitor binding sites for transition state analogs and small molecule inhibitors. J Biol Chem (2003) 1.05
Approach to radiation therapy in hepatocellular carcinoma. Cancer Treat Rev (2009) 1.03
Bone densitometry in pediatric populations: discrepancies in the diagnosis of osteoporosis by DXA and CT. J Pediatr (2005) 1.02
The unique mode of action of a divergent member of the ABA-receptor protein family in ABA and stress signaling. Cell Res (2013) 1.01
Over-expression of LAPTM4B is associated with poor prognosis and chemotherapy resistance in stages III and IV epithelial ovarian cancer. J Surg Oncol (2011) 1.01
Risk perceptions for avian influenza virus infection among poultry workers, China. Emerg Infect Dis (2013) 1.00
Insulin therapy restores impaired function and expression of P-glycoprotein in blood-brain barrier of experimental diabetes. Biochem Pharmacol (2008) 0.98
A rice calcium-dependent protein kinase OsCPK9 positively regulates drought stress tolerance and spikelet fertility. BMC Plant Biol (2014) 0.96
Anti-miRNA-23a oligonucleotide suppresses glioma cells growth by targeting apoptotic protease activating factor-1. Curr Pharm Des (2013) 0.95
Reactions of tris(amino)phosphines with arylsulfonyl azides: product dependency on tris(amino)phosphine structure. Inorg Chem (2003) 0.95
FEZF2, a novel 3p14 tumor suppressor gene, represses oncogene EZH2 and MDM2 expression and is frequently methylated in nasopharyngeal carcinoma. Carcinogenesis (2013) 0.95
Deoxycytidine kinase regulates the G2/M checkpoint through interaction with cyclin-dependent kinase 1 in response to DNA damage. Nucleic Acids Res (2012) 0.95
Expression profiles of microRNAs and their target genes in papillary thyroid carcinoma. Oncol Rep (2013) 0.94
The synergistic effects of traditional Chinese herbs and radiotherapy for cancer treatment. Oncol Lett (2013) 0.93
The tumor suppressor, p53, contributes to radiosensitivity of lung cancer cells by regulating autophagy and apoptosis. Cancer Biother Radiopharm (2012) 0.92
The novel function of advanced glycation end products in regulation of MMP-9 production. J Surg Res (2010) 0.91
Robust antimicrobial compounds and polymers derived from natural resin acids. Chem Commun (Camb) (2011) 0.90
Ischemic preconditioning attenuates renal ischemia-reperfusion injury by inhibiting activation of IKKbeta and inflammatory response. Am J Nephrol (2009) 0.90
Modulation of glucagon-like peptide-1 release by berberine: in vivo and in vitro studies. Biochem Pharmacol (2009) 0.90
Autophagy inhibition plays the synergetic killing roles with radiation in the multi-drug resistant SKVCR ovarian cancer cells. Radiat Oncol (2012) 0.90
ATM pathway is essential for ionizing radiation-induced autophagy. Cell Signal (2013) 0.89
Low-dose radiation-induced responses: focusing on epigenetic regulation. Int J Radiat Biol (2010) 0.89
Combined contributions of impaired hepatic CYP2C11 and intestinal breast cancer resistance protein activities and expression to increased oral glibenclamide exposure in rats with streptozotocin-induced diabetes mellitus. Drug Metab Dispos (2012) 0.88
The different regulatory effects of p53 status on multidrug resistance are determined by autophagy in ovarian cancer cells. Biomed Pharmacother (2012) 0.87
Water exchange enhanced cecal intubation in potentially difficult colonoscopy. Unsedated patients with prior abdominal or pelvic surgery: a prospective, randomized, controlled trial. Gastrointest Endosc (2013) 0.87
FRAT1 expression and its correlation with pathologic grade, proliferation, and apoptosis in human astrocytomas. Med Oncol (2009) 0.87
Effect of penguin and seal excrement on mercury distribution in sediments from the Ross Sea region, East Antarctica. Sci Total Environ (2012) 0.87
Insulin regulates P-glycoprotein in rat brain microvessel endothelial cells via an insulin receptor-mediated PKC/NF-kappaB pathway but not a PI3K/Akt pathway. Eur J Pharmacol (2008) 0.87
Aging decreases the contribution of MaxiK channel in regulating vascular tone in mesenteric artery by unparallel downregulation of α- and β1-subunit expression. Mech Ageing Dev (2013) 0.87
Berberine attenuates intestinal disaccharidases in streptozotocin-induced diabetic rats. Pharmazie (2008) 0.86
Knockdown of FRAT1 expression by RNA interference inhibits human glioblastoma cell growth, migration and invasion. PLoS One (2013) 0.86
High levels of methylmercury in guano and ornithogenic coral sand sediments on Xisha islands, South China sea. Arch Environ Contam Toxicol (2012) 0.86
Biological effects of low-dose radiation from computed tomography scanning. Int J Radiat Biol (2013) 0.86
Dietary high vanadium causes oxidative damage-induced renal and hepatic toxicity in broilers. Biol Trace Elem Res (2011) 0.85
Impaired function and expression of P-glycoprotein in blood-brain barrier of streptozotocin-induced diabetic rats. Brain Res (2006) 0.85
Virulent avian infectious bronchitis virus, People's Republic of China. Emerg Infect Dis (2012) 0.85
Bone selective protective effect of a novel bone-seeking estrogen on trabecular bone in ovariectomized rats. Calcif Tissue Int (2013) 0.84
Advances in the production, processing and microPET image quality of technetium-94m. Nucl Med Biol (2006) 0.84
MicroRNA-18a upregulates autophagy and ataxia telangiectasia mutated gene expression in HCT116 colon cancer cells. Mol Med Rep (2012) 0.84
Cascade removal and microPET imaging with 76Br. Phys Med Biol (2009) 0.84
Validated LC-MS/MS assay for the quantitative determination of clematichinenoside AR in rat plasma and its application to a pharmacokinetic study. Biomed Chromatogr (2012) 0.84
Knocking down SMC1A inhibits growth and leads to G2/M arrest in human glioma cells. Int J Clin Exp Pathol (2013) 0.84
DNA binding properties of 9-substituted harmine derivatives. Biochem Biophys Res Commun (2005) 0.83
Poorer survival of male breast cancer compared with female breast cancer patients may be due to biological differences. Jpn J Clin Oncol (2013) 0.83
Involvement of the ammonium transporter AmtB in nitrogenase regulation and ammonium excretion in Pseudomonas stutzeri A1501. Res Microbiol (2012) 0.83
Increased plasma exposures of five protoberberine alkaloids from Coptidis Rhizoma in streptozotocin-induced diabetic rats: is P-GP involved? Planta Med (2010) 0.82
The roles of AXIN2 in tumorigenesis and epigenetic regulation. Fam Cancer (2015) 0.81
Biocontrol of Gray Mold Decay in Pear by Bacillus amyloliquefaciens Strain BA3 and its Effect on Postharvest Quality Parameters. Pol J Microbiol (2016) 0.81
Inhibition of AMPK/autophagy potentiates parthenolide-induced apoptosis in human breast cancer cells. J Cell Biochem (2014) 0.80
WS2 nanosheet as a new photosensitizer carrier for combined photodynamic and photothermal therapy of cancer cells. Nanoscale (2014) 0.80
Effects of chronic cadmium poisoning on Zn, Cu, Fe, Ca, and metallothionein in liver and kidney of rats. Biol Trace Elem Res (2012) 0.80
Multifunctional self-fluorescent polymer nanogels for label-free imaging and drug delivery. Chem Commun (Camb) (2012) 0.80
Differentiation of choroid plexus tumors by advanced magnetic resonance spectroscopy. Neurosurg Focus (2005) 0.80
Aerobic exercise increases BK(Ca) channel contribution to regulation of mesenteric arterial tone by upregulating β1-subunit. Exp Physiol (2012) 0.80
Association of MDM2 polymorphism with risk and prognosis of leukemia: a meta-analysis. Acta Haematol (2015) 0.79
Renal protection by ischemic preconditioning is associated with p50/p50 homodimers. Am J Nephrol (2009) 0.79
Theoretical studies of blue-emitting iridium complexes with different ancillary ligands. J Phys Chem A (2008) 0.79
Stability analysis for neural networks with time-varying delay based on quadratic convex combination. IEEE Trans Neural Netw Learn Syst (2013) 0.79
Hyperammonemia enhances the function and expression of P-glycoprotein and Mrp2 at the blood-brain barrier through NF-κB. J Neurochem (2014) 0.79
Stathmin expression in glioma-derived microvascular endothelial cells: a novel therapeutic target. Oncol Rep (2011) 0.79
Dietary vanadium induces lymphocyte apoptosis in the bursa of Fabricius of broilers. Biol Trace Elem Res (2011) 0.79
Global transcriptome analysis of Mesorhizobium alhagi CCNWXJ12-2 under salt stress. BMC Microbiol (2014) 0.79
Two cases of non-intervention-related vascular intense spasm following stent implantation in the coronary artery. Exp Ther Med (2013) 0.79
Treatment of chronic bronchitis with modified ma xing shi gan tang and er chen tang. J Tradit Chin Med (2004) 0.78
A new near infrared photosensitizing nanoplatform containing blue-emitting up-conversion nanoparticles and hypocrellin A for photodynamic therapy of cancer cells. Nanoscale (2013) 0.78
Effects of extremely low frequency electromagnetic field on the health of workers in automotive industry. Electromagn Biol Med (2013) 0.78
Design of beta-carboline derivatives as DNA-targeting antitumor agents. Eur J Med Chem (2006) 0.78
Combined contributions of over-secreted glucagon-like peptide 1 and suppressed insulin secretion to hyperglycemia induced by gatifloxacin in rats. Toxicol Appl Pharmacol (2012) 0.78
Identification of the metabolites of anti-inflammatory compound clematichinenoside AR in rat intestinal microflora. Biomed Chromatogr (2013) 0.78
Degradable rosin-ester-caprolactone graft copolymers. Biomacromolecules (2011) 0.78
Dietary vanadium induces oxidative stress in the intestine of broilers. Biol Trace Elem Res (2011) 0.78
The role of affect in attentional functioning for younger and older adults. Front Psychol (2012) 0.78
The origin of the improved efficiency and stability of triphenylamine-substituted anthracene derivatives for OLEDs: a theoretical investigation. Chemphyschem (2008) 0.78
Kinetics study of pyridine biodegradation by a novel bacterial strain, Rhizobium sp. NJUST18. Bioprocess Biosyst Eng (2014) 0.78
Opposite effect of diabetes mellitus induced by streptozotocin on oral and intravenous pharmacokinetics of verapamil in rats. Drug Metab Dispos (2010) 0.78
Combined effects of epileptic seizure and phenobarbital induced overexpression of P-glycoprotein in brain of chemically kindled rats. Br J Pharmacol (2010) 0.78